Management of Incidental Findings in Clinical Genomic Sequencing

Current Protocols in Human Genetics

Volumn 87, Issue 1, 2015, Pages 9.23.1-9.23.16

  Krier, Joel B ^a   Green, Robert C ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

Author keywords

exome; genomics; incidental findings; secondary findings; sequencing; whole genome

Indexed keywords

ARTICLE; CLINICAL FEATURE; EXOME; GENOMICS; INCIDENTAL FINDING; PRACTICE GUIDELINE; PREVALENCE; GENETIC VARIATION; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN GENOME; INTERPERSONAL COMMUNICATION; MEDICAL GENETICS; PROCEDURES;

GENETIC VARIATION; GENETICS, MEDICAL; GENOME, HUMAN; GENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INCIDENTAL FINDINGS; TRUTH DISCLOSURE;

EID: 84988532388     PISSN: 19348266     EISSN: 19348258     Source Type: Journal    
DOI: 10.1002/0471142905.hg0923s87     Document Type: Article

References (84)

1. Abecasis, G.R, Auton, A, Brooks, L.D, DePristo, M.A, Durbin, R.M, Handsaker, R.E, Kang, H.M, Marth, G.T, and McVean, G.A. 2012. An integrated map of genetic variation from 1,092 human genomes. Nature 491:56-65. doi: 10.1038/nature11632
2. ACMG Board of Directors. 2015. ACMG policy statement: Updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing. Genet. Med. 17:68-69. doi: 10.1038/gim.2014.151
3. Adzhubei, I, Schmidt, S, Peshkin, L, Ramensky, V, Gerasimova, A, Bork, P, Kondrashov, A, and Sunyaev, S. 2010. A method and server for predicting damaging missense mutations. Nat. Methods 7:248-249. doi: 10.1038/nmeth0410-248
4. Ahmed, S, Horton, K.M, Jeffrey, R.B. Jr, Sheth, S, and Fishman, E.K. 2010. Incidental thyroid nodules on chest CT: Review of the literature and management suggestions. AJR Am. J. Roentgenol. 195:1066-1071. doi: 10.2214/AJR.10.4506
5. Alpert, J.B. and Naidich, D.P. 2011. Imaging of incidental findings on thoracic computed tomography. Radiol. Clin. North Am. 49:267-289. doi: 10.1016/j.rcl.2010.10.005
6. Aronson, S.J, Clark, E.H, Varugheese, M, Baxter, S, Babb, L.J, and Rehm, H.L. 2012. Communicating new knowledge on previously reported genetic variants. Genet. Med. 14:713-719. doi: 10.1038/gim.2012.19
7. Aronson, S.J, Clark, E.H, Babb, L.J, Baxter, S, Farwell, L.M, Funke, B.H, Hernandez, A.L, Joshi, V.A, Lyon, E, Parthum, A.R, Russell, F.J, Varugheese, M, Venman, T.C, and Rehm, H.L. 2011. The GeneInsight suite: A platform to support laboratory and provider use of DNA-based genetic testing. Hum. Mutat. 32:532-536. doi: 10.1002/humu.21470
8. Ashley, E.A, Butte, A.J, Wheeler, M.T, Chen, R, Klein, T.E, Dewey, F.E, Dudley, J.T, Ormond, K.E, Pavlovic, A, Morgan, A.A, Pushkarev, D, Neff, N.F, Hudgins, L, Gong, L, Hodges, L.M, Berlin, D.S, Thorn, C.F, Sangkuhl, K, Hebert, J.M, Woon, M, Sagreiya, H, Whaley, R, Knowles, J.W, Chou, M.F, Thakuria, J.V, Rosenbaum, A.M, Zaranek, A.W, Church, G.M, Greely, H.T, Quake, S.R, and Altman, R.B. 2010. Clinical assessment incorporating a personal genome. Lancet 375:1525-1535. doi: 10.1016/S0140-6736(10)60452-7
9. Bainbridge, M.N, Wiszniewski, W, Murdock, D.R, Friedman, J, Gonzaga-Jauregui, C, Newsham, I, Reid, J.G, Fink, J.K, Morgan, M.B, Gingras, M.C, Muzny, D.M, Hoang, L.D, Yousaf, S, Lupski, J.R, and Gibbs, R.A. 2011. Whole-genome sequencing for optimized patient management. Sci. Transl. Med. 3:87re83. doi: 10.1126/scitranslmed.3002243
10. Berg, J.S, Khoury, M.J, and Evans, J.P. 2011. Deploying whole genome sequencing in clinical practice and public health: Meeting the challenge one bin at a time. Genet. Med. 13:499-504. doi: 10.1097/GIM.0b013e318220aaba
11. Berg, J.S, Adams, M, Nassar, N, Bizon, C, Lee, K, Schmitt, C.P, Wilhelmsen, K.C, and Evans, J.P. 2013. An informatics approach to analyzing the incidentalome. Genet. Med. 1:36-44. doi: 10.1038/gim.2012.112
12. Boards of Directors, American Society of Human Genetics and American College of Medical Genetics. 1995. Points to consider: Ethical, legal, and psychosocial implications of genetic testing in children and adolescents. Am. J. Hum. Genet. 57:1233-1241.
13. Brauer, C.A. and Bozic, K.J. 2009. Using observational data for decision analysis and economic analysis. J. Bone Joint Surg. Am. 91:73-79. doi: 10.2106/JBJS.H.01537
14. Burke, W, Antommaria, A.H, Bennett, R, Botkin, J, Clayton, E.W, Henderson, G.E, Holm, I.A, Jarvik, G.P, Khoury, M.J, Knoppers, B.M, Press, N.A, Ross, L.F, Rothstein, M.A, Saal, H, Uhlmann, W.R, Wilfond, B, Wolf, S.M, and Zimmern, R. 2013. Recommendations for returning genomic incidental findings? We need to talk! Genet. Med. 15:854-859. doi: 10.1038/gim.2013.113
15. Cassa, C.A, Savage, S.K, Taylor, P.L, Green, R.C, McGuire, A.L, and Mandl, K.D. 2012. Disclosing pathogenic genetic variants to research participants: Quantifying an emerging ethical responsibility. Genome Res. 22:421-428. doi: 10.1101/gr.127845.111
16. Collins, F.S. and Varmus, H. 2015. A new initiative on precision medicine. N. Engl. J. Med. 372:793-795. doi: 10.1056/NEJMp1500523
17. Committee on Bioethics, American Academy of Pediatrics. 2001. Ethical issues with genetic testing in pediatrics. Pediatrics 107:1451-1455. doi: 10.1542/peds.107.6.1451
18. Cordero, P. and Ashley, E.A. 2012. Whole-genome sequencing in personalized therapeutics. Clin. Pharmacol. Therapeut. 91:1001-1009. doi: 10.1038/clpt.2012.51
19. Dorschner, M.O, Amendola, L.M, Turner, E.H, Robertson, P.D, Shirts, B.H, Gallego, C.J, Bennett, R.L, Jones, K.L, Tokita, M.J, Bennett, J.T, Kim, J.H, Rosenthal, E.A, Kim, D.S, National Heart, Lung, and Blood Institute Grand Opportunity Exome Sequencing Project, Tabor, H.K, Bamshad, M.J, Motulsky, A.G, Scott, C.R, Pritchard, C.C, Walsh, T, Burke, W, Raskind, W.H, Byers, P, Hisama, F.M, Nickerson, D.A, and Jarvik, G.P. 2013. Actionable, pathogenic incidental findings in 1,000 participants' exomes. Am. J. Hum. Genet. 93:631-640. doi: 10.1016/j.ajhg.2013.08.006
20. Downing, G.J. 2009. Key aspects of health system change on the path to personalized medicine. Transl. Res. 154:272-276. doi: 10.1016/j.trsl.2009.09.003
21. Duzkale, H, Shen, J, McLaughlin, H, Alfares, A, Kelly, M.A, Pugh, T.J, Funke, B.H, Rehm, H.L, and Lebo, M.S. 2013. A systematic approach to assessing the clinical significance of genetic variants. Clin. Genet. 84:453-463. doi: 10.1111/cge.12257
22. ENCODE Project Consortium. 2012. An integrated encyclopedia of DNA elements in the human genome. Nature 489:57-74. doi: 10.1038/nature11247
23. Evans, J.P. and Green, R.C. 2009. Direct to consumer genetic testing: Avoiding a culture war. Genet. Med. 11:568-569. doi: 10.1097/GIM.0b013e3181afbaed
24. Exome Aggregation Consortium (ExAC). http://exac.broadinstitute.org. Accessed May 5, 2015.
25. Feero, W.G, Guttmacher, A.E, and Collins, F.S. 2010. Genomic medicine—an updated primer. N. Engl. J. Med. 362:2001-2011. doi: 10.1056/NEJMra0907175
26. Fokkema, I.F, Taschner, P.E, Schaafsma, G.C, Celli, J, Laros, J.F, and den Dunnen, J.T. 2011. LOVD v.2.0: The next generation in gene variant databases. Hum. Mutat. 32:557-563. doi: 10.1002/humu.21438
27. Frueh, F.W, Greely, H.T, Green, R.C, Hogarth, S, and Siegel, S. 2011. The future of direct-to-consumer clinical genetic tests. Nat. Rev. Genet. 12:511-515. doi: 10.1038/nrg3026
28. Furtado, C.D, Aguirre, D.A, Sirlin, C.B, Dang, D, Stamato, S.K, Lee, P, Sani, F, Brown, M.A, Levin, D.L, and Casola, G. 2005. Whole-body CT screening: Spectrum of findings and recommendations in 1192 patients. Radiology 237:385-394. doi: 10.1148/radiol.2372041741
29. Gilissen, C, Hoischen, A, Brunner, H.G, and Veltman, J.A. 2011. Unlocking Mendelian disease using exome sequencing. Genome Biol. 12:228. doi: 10.1186/gb-2011-12-9-228
30. Gollust, S.E, Gordon, E.S, Zayac, C, Griffin, G, Christman, M.F, Pyeritz, R.E, Wawak, L, and Bernhardt, B.A. 2012. Motivations and perceptions of early adopters of personalized genomics: Perspectives from research participants. Public Health Genomics 15:22-30. doi: 10.1159/000327296
31. Gonzaga-Jauregui, C, Lupski, J.R, and Gibbs, R.A. 2012. Human genome sequencing in health and disease. Annu. Rev. Med. 63:35-61. doi: 10.1146/annurev-med-051010-162644
32. Green, R.C, Berg, J.S, Berry, G.T, Biesecker, L.G, Dimmock, D.P, Evans, J.P, Grody, W.W, Hegde, M.R, Kalia, S, Korf, B.R, Krantz, I, McGuire, A.L, Miller, D.T, Murray, M.F, Nussbaum, R.L, Plon, S.E, Rehm, H.L, and Jacob, H.J. 2012a. Exploring concordance and discordance for return of incidental findings from clinical sequencing. Genet. Med. 14:405-410. doi: 10.1038/gim.2012.21
33. Green, R.C, Mountain, J, Kiefer, A, Moreno, T, MacBean, E, Kalia, S.S, Roberts, J.S. and the PGen Study Group. 2012b. Consumer Genomics: Motivations and Intentions. American Society of Human Genetics, Annual Meeting. San Francisco, California. November 7, 2012.
34. Green, R.C, Berg, J.S, Grody, W.W, Kalia, S.S, Korf, B.R, Martin, C.L, McGuire, A, Nussbaum, R.L, O’Daniel, J.M, Ormond, K.E, Rehm, H.L, Watson, M.S, Williams, M.S, and Biesecker, L.G. 2013a. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet. Med. 15:565-574. doi:10.1038/gim.2013.73
35. Green, R.C, Lupski, J.R, and Biesecker, L.G. 2013b. Reporting genomic sequencing results to ordering clinicians: Incidental, but not exceptional. J. Am. Med. Assoc. 310:365-366. doi: 10.1001/jama.2013.41703
36. Green, R.C, Rehm, H.L, and Kohane, I. 2013c. Challenges in the clinical use of genome sequencing. In Genomic and Personalized Medicine, 2nd edition (H.F.G. Willard and G.S. Ginsburg, eds.). Academic Press, New York.
37. Guttmacher, A.E, McGuire, A.L, Ponder, B, and Stefansson, K. 2010. Personalized genomic information: Preparing for the future of genetic medicine. Nat. Rev. Genet. 11:161-165. doi: 10.1038/nrg2735
38. Jacob, H.J, Abrams, K, Bick, D.P, Brodie, K, Dimmock, D.P, Farrell, M, Geurts, J, Harris, J, Helbling, D, Joers, B.J, Kliegman, R, Kowalski, G, Lazar, J, Margolis, D.A, North, P, Northup, J, Roquemore-Goins, A, Scharer, G, Shimoyama, M, Strong, K, Taylor, B, Tsaih, S.W, Tschannen, M.R, Veith, R.L, Wendt-Andrae, J, Wilk, B, and Worthey, E.A. 2013. Genomics in clinical practice: Lessons from the front lines. Sci. Transl. Med. 5:194cm195. doi: 10.1126/scitranslmed.3006468
39. Johnston, J.J, Rubinstein, W.S, Facio, F.M, Ng, D, Singh, L.N, Teer, J.K, Mullikin, J.C, and Biesecker, L.G. 2012. Secondary variants in individuals undergoing exome sequencing: Screening of 572 individuals identifies high-penetrance mutations in cancer-susceptibility genes. Am. J. Hum. Genet. 91:97-108. doi: 10.1016/j.ajhg.2012.05.021
40. Jordan, D.M, Kiezum, A, Baxter, S.M, Agarwala, V, Green, R.C, Murray, M.F, Pugh, T, Lebo, M.S, Rehm, H.L, Funke, B.H, and Sunyaev, S. 2011. Development and validation of a computational method for assessment of missense variants in hypertrophic cardiomyopathy. Am. J. Hum. Genet. 88:183-192. doi: 10.1016/j.ajhg.2011.01.011
41. Jurgens, J, Ling, H, Hetrick, K, Pugh, E, Schiettecatte, F, Doheny, K, Hamosh, A, Avramopoulos, D, Valle, D, and Sobreira, N. 2015. Assessment of incidental findings in 232 whole-exome sequences from the Baylor-Hopkins Center for Mendelian Genomics. Genet. Med. (advance online publication, January 8, 2015). doi:10.1038/gim.2014.196
42. Kellis, M, Wold, B, Snyder, M.P, Bernstein, B.E, Kundaje, A, Marinov, G.K, Ward, L.D, Birney, E, Crawford, G.E, Dekker, J, Dunham, I, Elnitski, L.L, Farnham, P.J, Feingold, E.A, Gerstein, M, Giddings, M.C, Gilbert, D.M, Gingeras, T.R, Green, E.D, Guigo, R, Hubbard, T, Kent, J, Lieb, J.D, Myers, R.M, Pazin, M.J, Ren, B, Stamatoyannopoulos, J.A, Weng, Z, White, K.P, and Hardison, R.C. 2014. Defining functional DNA elements in the human genome. Proc. Natl. Acad. Sci. U.S.A. 111:6131-6138. doi: 10.1073/pnas.1318948111
43. Klitzman, R, Appelbaum, P.S, and Chung, W. 2013. Return of secondary genomic findings vs patient autonomy: Implications for medical care. J. Am. Med. Assoc. 310:369-370. doi: 10.1001/jama.2013.41709
44. Kohane, I.S, Masys, D.R, and Altman, R.B. 2006. The incidentalome: A threat to genomic medicine. JAMA 296:212-215. doi: 10.1001/jama.296.2.212
45. Kohane, I.S, Hsing, M, and Kong, S.W. 2012. Taxonomizing, sizing, and overcoming the incidentalome. Genet. Med. 14:399-404. doi: 10.1038/gim.2011.68
46. Kumar, P, Henikoff, S, and Ng, P.C. 2009. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat. Protoc. 4:1073-1081. doi: 10.1038/nprot.2009.86
47. Lautenbach, D, Christensen, K, Sparks, J, and Green, R.C. 2013. Communicating genetic risk information for common disorders in the era of genomic medicine. Annu. Rev. Genomics Hum. Genet. 14:491-513. doi: 10.1146/annurev-genom-092010-110722
48. Lee, H, Deignan, J.L, Dorrani, N, Strom, S.P, Kantarci, S, Quintero-Rivera, F, Das, K, Toy, T, Harry, B, Yourshaw, M, Fox, M, Fogel, B.L, Martinez-Agosto, J.A, Wong, D.A, Chang, V.Y, Shieh, P.B, Palmer, C.G, Dipple, K.M, Grody, W.W, Vilain, E, and Nelson, S.F. 2014. Clinical exome sequencing for genetic identification of rare Mendelian disorders. J. Am. Med. Assoc. 312:1880-1887. doi: 10.1001/jama.2014.14604
49. Lumbreras, B, Donat, L, and Hernandez-Aguado, I. 2010. Incidental findings in imaging diagnostic tests: A systematic review. Br. J. Radiol. 83:276-289. doi: 10.1259/bjr/98067945
50. MacConaill, L.E. and Garraway, L.A. 2010. Clinical implications of the cancer genome. J. Clin. Oncol. 28:5219-5228. doi: 10.1200/JCO.2009.27.4944
51. McDermott, U, Downing, J.R, and Stratton, M.R. 2011. Genomics and the continuum of cancer care. N. Engl. J. Med. 364:340-350. doi: 10.1056/NEJMp1014256
52. McGuire, A.L, Diaz, C.M, Wang, T, and Hilsenbeck, S.G. 2009. Social networkers’ attitudes toward direct-to-consumer personal genome testing. Am. J. Bioethics 9:3-10. doi: 10.1080/15265160902928209
53. McGuire, A.L, Joffe, S, Koenig, B.A, Biesecker, B.B, McCullough, L.B, Blumenthal-Barby, J.S, Caulfield, T, Terry, S.F, and Green, R.C. 2013. Point-counterpoint. Ethics and genomic incidental findings. Science 340:1047-1048. doi: 10.1126/science.1240156
54. McLaughlin, H.M, Ceyhan-Birsoy, O, Christensen, K.D, Kohane, I.S, Krier, J, Lane, W.J, Lautenbach, D, Lebo, M.S, Machini, K, MacRae, C.A, Azzariti, D.R, Murray, M.F, Seidman, C.E, Vassy, J.L, Green, R.C, Rehm, H.L, and for The MedSeq Project. 2014. A systematic approach to the reporting of medically relevant findings from whole genome sequencing. BMC Med. Genet. 15:134. doi: 10.1186/s12881-014-0134-1
55. Meisel, S.F, Carere, D.A, Wardle, J, Kalia, S.S, Moreno, T.A, Mountain, J.L, Roberts, J.S, and Green, R.C, for the PGEN Study Group. Explaining, not just predicting, drives interest in personal genomics. Genome Med. In press.
56. Meyerson, M, Gabriel, S, and Getz, G. 2010. Advances in understanding cancer genomes through second-generation sequencing. Nat. Rev. Genet. 11:685-696. doi: 10.1038/nrg2841
57. Moussa, I.D. 2011. Coronary artery bifurcation interventions: The disconnect between randomized clinical trials and patient centered decision-making. Catheter Cardiovasc. Interv. 77:537-545. doi: 10.1002/ccd.22865
58. Ng, P.C. and Henikoff, S. 2003. SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res. 31:3812-3814. doi: 10.1093/nar/gkg509
59. Petitti, D.B, Teutsch, S.M, Barton, M.B, Sawaya, G.F, Ockene, J.K, DeWitt, T, on behalf of the U.S. Preventive Services Task Force. 2009. Update on the methods of the U.S. Preventive Services Task Force: Insufficient evidence. Ann. Intern. Med. 150:199-205.
60. Relling, M.V. and Klein, T.E. 2011. CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network. Clin. Pharmacol. Ther. 89:464-467. doi: 10.1038/clpt.2010.279
61. Relling, M.V, Altman, R.B, Goetz, M.P, and Evans, W.E. 2010. Clinical implementation of pharmacogenomics: Overcoming genetic exceptionalism. Lancet Oncol. 11:507-509. doi: 10.1016/S1470-2045(10)70097-8
62. Richards, C.S, Bale, S, Bellissimo, D.B, Das, S, Grody, W.W, Hegde, M.R, Lyon, E, and Ward, B.E. 2008. ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007. Genet. Med. 10:294-300. doi: 10.1097/GIM.0b013e31816b5cae
63. Richards, S, Aziz, N, Bale, S, Bick, D, Das, S, Gastier-Foster, J, Grody, W.W, Hegde, M, Lyon, E, Spector, E, Voelkerding, K, and Rehm, H.L. 2015. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17:405-423. doi: 10.1038/gim.2015.30
64. Roberts, J.S, Christensen, K.D, and Green, R.C. 2011. Using Alzheimer's disease as a model for genetic risk disclosure: Implications for personal genomics. Clin Genet. 80:407-414. doi: 10.1111/j.1399-0004.2011.01739.x
65. Rogers, A.J, Maher, C.O, Schunk, J.E, Quayle, K, Jacobs, E, Lichenstein, R, Powell, E, Miskin, M, Dayan, P, Holmes, J.F, Kuppermann, N, for the Pediatric Emergency Care Applied Research Network. 2013. Incidental findings in children with blunt head trauma evaluated with cranial CT scans. Pediatrics 132:e356-e363. doi: 10.1542/peds.2013-0299
66. Ross, L.F, Rothstein, M.A, and Clayton, E.W. 2013. Mandatory extended searches in all genome sequencing: “incidental findings,” patient autonomy, and shared decision making. J. Am. Med. Assoc. 310:367-368. doi: 10.1001/jama.2013.41700
67. Samuels, M.E. and Rouleau, G.A. 2011. The case for locus-specific databases. Nat. Rev. Genet. 12:378-379. doi: 10.1038/nrg3011
68. Saunders, C.J, Miller, N.A, Soden, S.E, Dinwiddie, D.L, Noll, A, Alnadi, N.A, Andraws, N, Patterson, M.L, Krivohlavek, L.A, Fellis, J, Humphray, S, Saffrey, P, Kingsbury, Z, Weir, J.C, Betley, J, Grocock, R.J, Margulies, E.H, Farrow, E.G, Artman, M, Safina, N.P, Petrikin, J.E, Hall, K.P, and Kingsmore, S.F. 2012. Rapid whole-genome sequencing for genetic disease diagnosis in neonatal intensive care units. Sci. Transl. Med. 4:154ra135. doi: 10.1126/scitranslmed.3004041
69. Schweiger, M.R, Barmeyer, C, and Timmermann, B. 2013. Genomics and epigenomics: New promises of personalized medicine for cancer patients. Brief Funct. Genomics 12:411-421. doi: 10.1093/bfgp/elt024
70. Stenson, P, Mort, M, Ball, E, Howells, K, Phillips, A, Thomas, N, and Cooper, D. 2009. The human gene mutation database: 2008 update. Genome Med. 1:13. doi: 10.1186/gm13
71. Tong, M.Y, Cassa, C.A, and Kohane, I.S. 2011. Automated validation of genetic variants from large databases: Ensuring that variant references refer to the same genomic locations. Bioinformatics 27:891-893. doi: 10.1093/bioinformatics/btr029
72. Travis, S.P. 2006. New thinking: Theory vs practice. A case study illustrating evidence-based therapeutic decision making. Colorectal Dis. 8:25-29. doi: 10.1111/j.1463-1318.2006.00989.x
73. Van Vugt, S, Broekhuizen, L, Zuithoff, N, de Jong, P, Butler, C, Hood, K, Coenen, S, Goossens, H, Little, P, Almirall, J, Blasi, F, Chlabicz, S, Davies, M, Godycki-Cwirko, M, Hupkova, H, Kersnik, J, Mierzecki, A, Molstad, S, Moore, M, Schaberg, T, De Sutter, A, Torres, A, Touboul, P, and Verheij, T, and On behalf of the GRACE Project Group. 2012. Incidental chest radiographic findings in adult patients with acute cough. Ann. Fam. Med. 10:510-515. doi: 10.1370/afm.1384
74. Varmus, H. 2010. Ten years on—the human genome and medicine. N. Engl. J. Med. 362:2028-2029. doi: 10.1056/NEJMe0911933
75. Vassy, J.L, Korf, B.R, and Green, R.C. 2015. How to know when physicians are ready to use genomic medicine. Sci. Transl. Med. 7:287fs19.
76. Vassy, J.L, Christensen, K.D, Slashinski, M.J, Lautenbach, D.M, Raghavan, S, Robinson, J.O, Blumenthal-Barby, J, Feuerman, L.Z, Lehmann, L.S, Murray, M.F, Green, R.C, and McGuire, A.L. 2015. ‘Someday it will be the norm': Physician perspectives on the utility of genome sequencing for patient care in the MedSeq Project. Per. Med. 12:23-32. doi: 10.2217/pme.14.68
77. Wiita, A.P. and Schrijver, I. 2011. Clinical application of high throughput molecular screening techniques for pharmacogenomics. Pharmgenomics. Pers. Med. 4:109-121.
78. Wilfond, B.S, Fernandez, C.V, and Green, R.C. 2015. Disclosing secondary findings from genomic sequencing to families: considering the “Benefit to Families”. J. Law Med. Ethics. In press.
79. Wolf, S.M, Annas, G.J, and Elias, S. 2013. Point-counterpoint. Patient autonomy and incidental findings in clinical genomics. Science 340:1049-1050. doi: 10.1126/science.1239119
80. Worthey, E.A, Mayer, A.N, Syverson, G.D, Helbling, D, Bonacci, B.B, Decker, B, Serpe, J.M, Dasu, T, Tschannen, M.R, Veith, R.L, Basehore, M.J, Broeckel, U, Tomita-Mitchell, A, Arca, M.J, Casper, J.T, Margolis, D.A, Bick, D.P, Hessner, M.J, Routes, J.M, Verbsky, J.W, Jacob, H.J, and Dimmock, D.P. 2011. Making a definitive diagnosis: Successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Genet. Med. 13:255-262. doi: 10.1097/GIM.0b013e3182088158
81. Wright, C, Burton, H, Hall, A, Moorthie, S, Pokorska-Bocci, A, Sagoo, G, Sanderson, S, and Skinner, R. 2011. Next steps in the sequence. The implications of whole genome sequencing for health in the UK. PHG Foundation. http://www.phgfoundation.org
82. Xue, Y, Chen, Y, Ayub, Q, Huang, N, Ball, E.V, Mort, M, Phillips, A.D, Shaw, K, Stenson, P.D, Cooper, D.N, and Tyler-Smith, C. 2012. Deleterious- and disease-allele prevalence in healthy individuals: Insights from current predictions, mutation databases, and population-scale resequencing. Am. J. Hum. Genet. 91:1022-1032. doi: 10.1016/j.ajhg.2012.10.015
83. Yang, Y, Muzny, D.M, Reid, J.G, Bainbridge, M.N, Willis, A, Ward, P.A, Braxton, A, Beuten, J, Xia, F, Niu, Z, Hardison, M, Person, R, Bekheirnia, M.R, Leduc, M.S, Kirby, A, Pham, P, Scull, J, Wang, M, Ding, Y, Plon, S.E, Lupski, J.R, Beaudet, A.L, Gibbs, R.A, and Eng, C.M. 2013. Clinical whole-exome sequencing for the diagnosis of Mendelian disorders. N. Engl. J. Med. 369:1502-1511. doi: 10.1056/NEJMoa1306555
84. Yang, Y, Muzny, D.M, Xia, F, Niu, Z, Person, R, Ding, Y, Ward, P, Braxton, A, Wang, M, Buhay, C, Veeraraghavan, N, Hawes, A, Chiang, T, Leduc, M, Beuten, J, Zhang, J, He, W, Scull, J, Willis, A, Landsverk, M, Craigen, W.J, Bekheirnia, M.R, Stray-Pedersen, A, Liu, P, Wen, S, Alcaraz, W, Cui, H, Walkiewicz, M, Reid, J, Bainbridge, M, Patel, A, Boerwinkle, E, Beaudet, A.L, Lupski, J.R, Plon, S.E, Gibbs, R.A, and Eng, C.M. 2014. Molecular findings among patients referred for clinical whole-exome sequencing. J. Am. Med. Assoc. 312:1870-1879. doi: 10.1001/jama.2014.14601